Back
Intra-Cellular Therapies Vs. AbbVie Industry Stock Comparison
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
77.09
Seasonality Move:
27.94%
Sell
37
ABBV
AbbVie
Last Price:
189.10
Seasonality Move:
11.86%
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $77.09. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $188.76. The Score for ABBV is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $77.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight selling pressure.
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 58.08 | Buy |
| Chaikin Money Flow: | -3459 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.66 - 76.4) | Buy |
| Bollinger Bands (100): | (70.6 - 77.3) | Buy |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.16 | Sell |
| Relative Strength Index (14 RSI): | 40.57 | Sell |
| Chaikin Money Flow: | 2707634 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.71 - 195.83) | Sell |
| Bollinger Bands (100): | (171.26 - 195.96) | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.79 | Buy |
| 20-day SMA: | 74.15 | Buy |
| 50-day SMA: | 74.47 | Buy |
| 200-day SMA: | 71.38 | Buy |
| 8-day EMA: | 75.95 | Buy |
| 20-day EMA: | 74.93 | Buy |
| 50-day EMA: | 74.5 | Buy |
| 200-day EMA: | 70.77 | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 191.33 | Sell |
| 20-day SMA: | 193.23 | Sell |
| 50-day SMA: | 194.25 | Sell |
| 200-day SMA: | 176.54 | Buy |
| 8-day EMA: | 190.5 | Sell |
| 20-day EMA: | 192.37 | Sell |
| 50-day EMA: | 191.13 | Sell |
| 200-day EMA: | 177.07 | Buy |
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $1.12 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $1.21 per share.
Intra-Cellular Therapies Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||